HK1053601A1 - Pharmaceutical composition for the controlled release of paracetamol - Google Patents

Pharmaceutical composition for the controlled release of paracetamol

Info

Publication number
HK1053601A1
HK1053601A1 HK03104302.2A HK03104302A HK1053601A1 HK 1053601 A1 HK1053601 A1 HK 1053601A1 HK 03104302 A HK03104302 A HK 03104302A HK 1053601 A1 HK1053601 A1 HK 1053601A1
Authority
HK
Hong Kong
Prior art keywords
paracetamol
pharmaceutical composition
controlled release
release phase
unique
Prior art date
Application number
HK03104302.2A
Other languages
English (en)
Inventor
Shing Yue Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1053601(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1053601A1 publication Critical patent/HK1053601A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK03104302.2A 2000-04-19 2003-06-16 Pharmaceutical composition for the controlled release of paracetamol HK1053601A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (1)

Publication Number Publication Date
HK1053601A1 true HK1053601A1 (en) 2003-10-31

Family

ID=9890126

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03104302.2A HK1053601A1 (en) 2000-04-19 2003-06-16 Pharmaceutical composition for the controlled release of paracetamol

Country Status (25)

Country Link
US (2) US7943170B2 (hu)
EP (1) EP1274402B1 (hu)
JP (1) JP2003531165A (hu)
KR (1) KR100845660B1 (hu)
CN (1) CN100335046C (hu)
AT (1) ATE438388T1 (hu)
AU (2) AU2001260212C1 (hu)
BR (1) BR0110129A (hu)
CA (1) CA2406373C (hu)
CO (1) CO5280073A1 (hu)
CY (1) CY1109483T1 (hu)
CZ (1) CZ303275B6 (hu)
DE (1) DE60139462D1 (hu)
DK (1) DK1274402T3 (hu)
EA (1) EA006103B1 (hu)
ES (1) ES2329971T3 (hu)
GB (1) GB0009522D0 (hu)
HK (1) HK1053601A1 (hu)
HU (1) HU230033B1 (hu)
MX (1) MXPA02010347A (hu)
NZ (1) NZ521799A (hu)
TW (1) TWI282286B (hu)
UA (1) UA76417C2 (hu)
WO (1) WO2001080834A1 (hu)
ZA (1) ZA200208084B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CN100348974C (zh) * 2003-09-30 2007-11-14 北京东方凯恩医药科技有限公司 一种药物组合物的检测方法
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
CA2616204C (en) 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
CA2678092C (en) * 2007-10-16 2013-07-30 Labopharm Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
AU2008338207A1 (en) 2007-12-17 2009-06-25 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
MX2010009990A (es) 2008-03-11 2010-12-15 Depomed Inc Formas de dosificación gástricas retentivas de liberación prolongada que comprenden combinaciones de un analgésico no opioide y un analgésico opioide.
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CA2746888C (en) 2008-12-16 2015-05-12 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
RU2012112552A (ru) * 2009-08-31 2013-10-10 Дипомед, Инк. Удерживаемые в желудке фармацевтические композиции для немедленного и продленного высвобождения ацетаминофена
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
CA2835330A1 (en) * 2011-05-06 2012-11-15 Glaxosmithkline Llc Sustained release paracetamol formulations
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US20140206740A1 (en) * 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
JP6266635B2 (ja) * 2012-10-18 2018-01-24 アッヴィ・インコーポレイテッド ピリミジンジオン誘導体化合物の製剤
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
AU2017230974B2 (en) * 2016-03-09 2022-02-03 Nls-1 Pharma Ag A mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
US6126967A (en) 1998-09-03 2000-10-03 Ascent Pediatrics Extended release acetaminophen particles
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability

Also Published As

Publication number Publication date
CO5280073A1 (es) 2003-05-30
CN1426298A (zh) 2003-06-25
CN100335046C (zh) 2007-09-05
EA006103B1 (ru) 2005-08-25
HUP0300698A2 (hu) 2003-07-28
ATE438388T1 (de) 2009-08-15
US20040202716A1 (en) 2004-10-14
DK1274402T3 (da) 2009-11-16
US20110177168A1 (en) 2011-07-21
KR100845660B1 (ko) 2008-07-10
WO2001080834A1 (en) 2001-11-01
EP1274402A1 (en) 2003-01-15
EP1274402B1 (en) 2009-08-05
ZA200208084B (en) 2003-10-08
HU230033B1 (hu) 2015-05-28
CA2406373C (en) 2010-06-29
GB0009522D0 (en) 2000-06-07
CZ303275B6 (cs) 2012-07-11
AU2001260212B2 (en) 2006-09-21
BR0110129A (pt) 2002-12-31
PL358123A1 (en) 2004-08-09
CY1109483T1 (el) 2014-08-13
EA200200954A1 (ru) 2003-04-24
DE60139462D1 (de) 2009-09-17
JP2003531165A (ja) 2003-10-21
AU2001260212C1 (en) 2020-07-16
UA76417C2 (en) 2006-08-15
CZ20023470A3 (cs) 2003-03-12
NZ521799A (en) 2004-12-24
HUP0300698A3 (en) 2004-09-28
TWI282286B (en) 2007-06-11
CA2406373A1 (en) 2001-11-01
MXPA02010347A (es) 2003-04-25
US7943170B2 (en) 2011-05-17
ES2329971T3 (es) 2009-12-03
KR20030009440A (ko) 2003-01-29
AU6021201A (en) 2001-11-07

Similar Documents

Publication Publication Date Title
HK1053601A1 (en) Pharmaceutical composition for the controlled release of paracetamol
EP1187602A4 (en) SUSTAINABLE RELEASE INJECTABLE PHARMACEUTICAL COMPOSITION AND METHODS OF PREPARING THE SAME
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
TWI235068B (en) Sustained-release pharmaceutical composition
AU6872201A (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
HK1060305A1 (en) Contraception process and administration form for the same
EP1344780A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZOLE DERIVATIVES, MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION
AU5985001A (en) Process for increasing the softness of base webs and products made therefrom
AU5367501A (en) Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
PL366622A1 (en) Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
ZA200402858B (en) Novel beta-phenyl-alpha-oxysubstituted propionic derivatives; process for its preparation and their use in the preparation of pharmaceutically important compounds.
HK1081855A1 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
AU2000273085A1 (en) Sustained release pharmaceutical compositions containing metformin and method ofits production
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
MY136370A (en) Oxazolidinone tablet formulation
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
GB0225534D0 (en) Sustained release pharmaceutical composition containing glipizide and method for producing same
HK1044719A1 (en) Sustained release salts of pharmaceutically activepeptides and process for production
AU5220800A (en) Combination of mtp inhibitors and lipid reducers and the use thereof in medicaments
AU2002221139A1 (en) Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
NZ521515A (en) Composition comprising paracetamol and niflumic acid
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
GB2369297B (en) A sustained release and long residing opthalmic formulation and the process of preparing the same
AU2002235767A1 (en) Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists
MY134931A (en) Oral galantamine solution

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20210411